Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change Price Change
grade A 1.11 0.91% 0.01
ACST closed up 0.91 percent on Friday, January 18, 2019, on 56 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ACST trend table...

Date Alert Name Type % Chg
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 17 1,2,3 Pullback Bullish Bullish Swing Setup 0.91%
Jan 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.91%
Jan 17 Wide Bands Range Expansion 0.91%
Jan 17 Overbought Stochastic Strength 0.91%
Jan 16 1,2,3 Pullback Bullish Bullish Swing Setup 1.83%
Jan 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.83%
Jan 16 Wide Bands Range Expansion 1.83%

Older signals for ACST ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Is ACST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.8
52 Week Low 0.43
Average Volume 595,963
200-Day Moving Average 0.7745
50-Day Moving Average 0.8113
20-Day Moving Average 0.9258
10-Day Moving Average 1.067
Average True Range 0.0715
ADX 40.24
+DI 34.9625
-DI 12.2839
Chandelier Exit (Long, 3 ATRs ) 0.9355
Chandelier Exit (Short, 3 ATRs ) 0.8745
Upper Bollinger Band 1.2495
Lower Bollinger Band 0.6021
Percent B (%b) 0.78
BandWidth 69.92871
MACD Line 0.0982
MACD Signal Line 0.0782
MACD Histogram 0.02
Fundamentals Value
Market Cap 16.33 Million
Num Shares 14.7 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -1.44
Price-to-Sales 0.00
Price-to-Book 1.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.23
Resistance 3 (R3) 1.23 1.18 1.21
Resistance 2 (R2) 1.18 1.15 1.19 1.20
Resistance 1 (R1) 1.15 1.13 1.17 1.15 1.20
Pivot Point 1.10 1.10 1.11 1.11 1.10
Support 1 (S1) 1.07 1.07 1.09 1.07 1.02
Support 2 (S2) 1.02 1.05 1.03 1.02
Support 3 (S3) 0.99 1.02 1.01
Support 4 (S4) 0.99